Galileo
Our aim is to significantly improve the success rate of new drugs by raising the capabilities of microfluidic cell culture and analysis to take the diagnosis, drug discovery and development pipeline to a new level.
The prestigious EIC Transition grant enables us to develop an innovative wide range flow sensor from proof-of-concept to full prototype for beta testing with a budget of 1.67 million Euros.
